• 1
    Yaksh TL. Opioid receptor systems and the endorphins: A review of their spinal organization. J Neurosurg 1987;67:157176.
  • 2
    Tiano MJ, Walker EA, Dykstra LA. Cross-tolerance to etorphine differentiates mu-opioid agonists in a rat tail withdrawal assay. Analgesia 1998;3:251257.
  • 3
    Lawhorn CD, Brown RE. Epidural morphine with butorphanol in pediatric patients. J Clin Anesth 1994;6:9194.
  • 4
    Wittels B., Glosten B., Faure EAM, et al. Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: Maternal outcomes. Anesth Analg 1993;77:925932.
  • 5
    Lawhorn CD, McNitt JD, Fibuch EE, et al. Epidural morphine with butorphanol for postoperative analgesia after cesarean delivery. Anesth Analg 1991;72:5357.
  • 6
    Gambling DR, Howell P., Huber C., et al. Epidural butorphanol does not reduce side effects from epidural morphine after cesarean birth. Anesth Analg 1994;78:10991104.
  • 7
    Parker RK, Holtmann B., White PF. Patient-controlled epidural analgesia: Interactions between nalbuphine and hydromorphone. Anesth Analg 1997;84:757763.
  • 8
    Osgood PF, Kazianis A., Kemp JW, et al. Dose effects of morphine and butorphanol alone and in combination after burn injury in the rat. J Burn Care Rehabil 1995;16:394399.
  • 9
    Briggs SL, Sneed K., Sawyer DC. Antinociceptive effects of oxy-morphone-butorphanol-acepromazine combination in cats. Vet Surg 1998;27:466472.
  • 10
    Pettifer G., Dyson D. Hydromorphone: A cost-effective alternative to the use of oxymorphone. Can Vet J 2000;41:135137.
  • 11
    Wagner AE. Is butorphanol analgesic in dogs and cats Vet Med 1999;4:346350.
  • 12
    Carroll GL, Howe LB, Slater MR, et al. Evaluation of analgesia provided by postoperative administration of butorphanol to cats undergoing onychectomy. J Am Vet Med Assoc 1998;213:246250.
  • 13
    Gellasch KL, Kruse-Elliott KT, Osmond CS, et al. Comparison of transdermal administration of fentanyl versus intramuscular administration of butorphanol for analgesia after onychectomy in cats. J Am Vet Med Assoc 2002;220:10201024.
  • 14
    Ansah OB, Vainio O., Hellsten C., et al. Postoperative pain control in cats: Clinical trials with medetomidine and butorphanol. Vet Surg 2002;31:99103.
  • 15
    Dixon MJ, Robertson SA, Taylor PM. A thermal threshold testing device for evaluation of analgesics in cats. Res Vet Sci 2002;72:205210.
  • 16
    Beecher HK. The measurement of pain. Prototype for the quantitative study of subjective responses. Pharmacol Rev 1957; 9: 59209.
  • 17
    Tyers MB. A classification of opiate receptors that mediate no-ciception in animals. Br J Pharmacol 1980;69:503512.
  • 18
    Meller ST, Dykstra C., Gebhart GF. Acute thermal hyperalgesia in the rat is produced by activation of N-methyl-D-aspartate receptors and protein kinase C and production of nitric oxide. Neuroscience 1996;71:327335.
  • 19
    Meller ST, Dykstra CL, Gebhart GF. Acute mechanical hyper-algesia is produced by coactivation of AMPA and metabotropic glu-tamate receptors. Neuroreport 1993;4:879882.
  • 20
    Dubner R., Sumino R., Starkman S. Responses of facial cutaneous thermosensitive and mechanosensitive afferent fibers in the monkey to noxious heat stimulation. Adv Neurol 1974;4:6171.
  • 21
    Price DD, Harkins SW, Rafii A., et al. A simultaneous comparison of fentanyl's analgesic effects on experimental and clinical pain. Pain 1986;24:197203.
  • 22
    Campbell IG, Carstens E., Watkins LR. Comparison of human pain sensation and flexion withdrawal evoked by noxious radiant heat. Pain 1991;45:259268.
  • 23
    Carstens E., Watkins LR. Inhibition of the responses of neurons in the rat spinal cord to noxious skin heating by stimulation in mid-brain periaqueductal gray or lateral reticular formation. Brain Res 1986;382:266277.
  • 24
    Hardy JD, Jacobs I., Meizner MD. Thresholds of pain and reflex contraction as related to noxious stimulation. J Appl Physiol 1953;5:725739.
  • 25
    Taber RI. Predictive value of analgesic assays in mice and rats. Adv Biochem Psychopharmacol 1973;8:191211.
  • 26
    Carstens E., Campbell IG. Parametric and pharmacological studies of midbrain suppression of the hind limb flexion withdrawal reflex in the rat. Pain 1988;33:201213.
  • 27
    Nolan A., Waterman AE, Livingston A. The correlation of the thermal and mechanical antinociceptive activity of pethidine hydro-chloride with plasma concentrations of the drug in sheep. J Vet Pharmacol Ther 1988;11:94102.
  • 28
    Watkins LR. Algesiometry in laboratory animals and man: Current concepts and future directions. In: ChapmanCR, LoeserJD, eds. Issues in Pain Management. New York , NY : Raven Press; 1989: 249265.
  • 29
    D'Amour FE, Smith DL. A method for determining loss of pain sensation. J Pharmacol Exp Ther 1941;72:7479.
  • 30
    Price DD, von der Gruen A., Miller J., et al. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecys-tokinin antagonist. Anesth Analg 1985;64:801806.
  • 31
    Watkins LR, Kinscheck IB, Mayer DJ. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science 1984;224:395396.
  • 32
    Casey KL, Morrow TJ. Nocifensive responses to cutaneous thermal stimuli in the cat: Stimulus-response profiles, latencies, and afferent activity. J Neurophysiol 1983;50:14971515.
  • 33
    Li CY, Morrow TJ, Casey KL. Responses of single cutaneous fibers to noxious thermal pulse stimulation of cat upper hind limb. Pain 1985;21:1724.
  • 34
    Slingsby LS, Jones AE, Waterman-Pearson AE. Use of a new finger-mounted device to compare mechanical nociceptive thresholds in cats given pethidine or no medication after castration. Res Vet Sci 2001; 70: 243246.
  • 35
    Slingsby LS, Waterman-Pearson AE. Comparison of pethidine, buprenorphine and ketoprofen for postoperative analgesia after ovar-iohysterectomy in the cat. Vet Rec 1998;143:185189.
  • 36
    Lascelles BDX, Cripps PJ, Mirchandani S., et al. Carprofen as an analgesic for postoperative pain in cats: Dose titration and assessment of efficacy in comparison to pethidine hydrochloride. J Small Anim Pract 1995;36:535541.
  • 37
    Robertson SA, Taylor PM, Lascelles BD, et al. Analgesia in the cat: Effects of buprenorphine, butorphanol and morphine on thermal thresholds. Vet Rec 2003;153:462465.
  • 38
    Stanway GW, Taylor PM, Brodbelt DC. A preliminary investigation comparing pre-operative morphine and buprenorphine for postoperative analgesia and sedation in cats. Vet Anaesth Analg 2002; 29:2935.
  • 39
    Dyck PJ, Zimmerman IR, Johnson DM, et al. A standard test of heat-pain responses using CASE IV. J Neurol Sci 1996;136:5463.
  • 40
    Wu G., Campbell JN, Meyer RA. Effects of baseline skin temperature on pain ratings to suprathreshold temperature-controlled stimuli. Pain 2001;90:151156.
  • 41
    Sawyer DC, Rech RH. Analgesia and behavioral effects of bu-torphanol, nalbuphine, and pentazocine in the cat. J Am Anim Hosp Assoc 1987;23:438446.
  • 42
    Sawyer DC, Rech RH, Durham RA. Does ketamine provide adequate visceral analgesia when used alone or in combination with acepromazine, diazepam, or butorphanol in cats. J Am Anim Hosp Assoc 1993;29:257263.
  • 43
    Mandsager RE, Raffe MR. Evaluation of periosteal nociception in the cat. Prog Vet Neurol 1991;2:237242.
  • 44
    Morgan D., Cook CD, Smith MA, et al. An examination of the interactions between the antinociceptive effects of morphine and var-ious |x-opioids: The role of intrinsic efficacy and stimulus intensity. Anesth Analg 1999; 88: 407413.
  • 45
    Leander JD. Evidence that nalorphine, butorphanol and oxilor-phan are partial agonists at a kappa-opioid receptor. Eur J Pharmacol 1983;86:467470.
  • 46
    Horan PJ, Ho IK. Comparative pharmacological and biochemical studies between butorphanol and morphine. Pharmacol Biochem Behav 1989;34:847854.
  • 47
    Dykstra LA. Butorphanol, levallorphan, nalbuphine and nalorphine as antagonists in the squirrel monkey. J Pharmacol Exp Ther 1990;254:245252.
  • 48
    Walsh SL, Strain EC, Abreu ME, et al. Enadoline, a selective kappa opioid agonist: Comparison with butorphanol and hydromor-phone in humans. Psychopharmacology (Berlin) 2001;157:151162.
  • 49
    Picker MJ, Benyas S., Horwitz JA, et al. Discriminative stimulus effects of butorphanol: Influence of training dose on the substitution patterns produced by mu, kappa and delta opioid agonists. J Pharmacol Exp Ther 1996;279:11301141.
  • 50
    Dykstra LA, Preston KL, Bigelow GE. Discriminative stimulus and subjective effects of opioids with mu and kappa activity: Data from laboratory animals and human subjects. Psychopharmacology (Berlin) 1997;130:1427.
  • 51
    Butelman ER, Winger G., Zernig G., et al. Butorphanol: Characterization of agonist and antagonist effects in rhesus monkeys. J Pharmacol Exp Ther 1995;272:845853.
  • 52
    Vivian JA, DeYoung MB, Sumpter TL, et al. kappa-Opioid receptor effects of butorphanol in rhesus monkeys. J Pharmacol Exp Ther 1999;290:259265.
  • 53
    Flecknell PA, Liles JH, Wootton R. Reversal of fentanyl/fluan-isone neuroleptanalgesia in the rabbit using mixed agonist/antagonist opioids. Lab Anim 1989;23:147155.
  • 54
    Crain SM, Shen KF. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 2000;84:121131.